Shire plc (SHPGY)
Q2 2011 Earnings Call
July 28, 2011 9:00 am ET
Graham Hetherington - Chief Financial Officer, Principal Accounting Officer and Director
Angus Russell - Chief Executive Officer and Executive Director
Sylvie Gregoire - Member of Management Committee and President of Human Genetic Therapies Business
Eric Rojas - Director of Investor Relations - North America
Michael Cola - President of Specialty Pharmaceuticals, Member of Senior Staff Committee and Member of Management Committee
Florent Cespedes - Exane BNP Paribas
William Tanner - Lazard Capital Markets LLC
David Steinberg - Deutsche Bank AG
Ken Cacciatore - Cowen and Company, LLC
Brian Bourdot - Barclays Capital
Peter Verdult - Morgan Stanley
Brian White - Shore Capital Group plc
Timothy Chiang - CRT Capital Group LLC
David Buck - Buckingham Research Group, Inc.
Justin Smith - MF Global UK Limited
Keyur Parekh - Goldman Sachs Group Inc.
Gary Nachman - Susquehanna Financial Group, LLLP
Good day, ladies and gentlemen, and welcome to the Shire's 2011 Second Quarter Results Call, hosted by Angus Russell. My name is Phoebe, and I'm your event manager. [Operator Instructions] I'd like to advise all parties this conference is being recorded for replay purposes, and I'd like to hand over to Eric Rojas. Please go ahead, Eric.
Thanks, Phoebe. Good morning and good afternoon, everyone. Thank you for joining us today for Shire's Second Quarter 2011 Financial Results.
By now, you should have all received our press release and should be viewing our presentation via our website on shire.com. If for some reason you have not received the press release or unable to access our website, please contact Souheil Salah in our U.K. Investor Relations department on +44 1256 894 160, and he'll be happy to assist you.